Pricing and reimbursement policies in new EU accession countries

Journal of Generic Medicines

Volumn 4, Issue 4, 2007, Pages 249-258

  Kazakov, Rossen ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GENERIC DRUG;

ARTICLE; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG INDUSTRY; DRUG LEGISLATION; DRUG MARKETING; ECONOMIC EVALUATION; EUROPE; GEOGRAPHY; GOVERNMENT REGULATION; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE SYSTEM; LICENSING; POLITICS; PROSPECTIVE PRICING; REIMBURSEMENT; SOCIOECONOMICS;

EID: 34447287830     PISSN: 17411343     EISSN: 17417090     Source Type: Journal    
DOI: 10.1057/palgrave.jgm.4950068     Document Type: Article

References (10)

1. Permanand, G. & Mossialos, E. (2004). Theorising the development of the European Union framework for pharmaceutical regulation. Discussion paper Number 13, LSE Health and Social Care, London, pp. 28-30.
2. Siebert, C. (2006). Generic medicines policies in the EU and the role of the Pharmaceutical forum. Presentation at EGA seminar on 'Generics Medicines and Pricing and Reimbursement Systems in Europe', 6th April, 2006, Brussels, Belgium.
3. Saltchev, P. (2004). Strategies for pricing of pharmaceuticals in the accession period to the EU. Presentation at conference of DG Enlargement in cooperation with the Bulgarian Ministry of Health, 5-6 April, Sofia, Bulgaria.
4. Kazakov, R. (2006). Between strategy and change. Reformulating the generic industry from CEE. Presentation at 'Sales and Marketing in Generics' conference, 8-9 November, Lisbon, Portugal.
5. Hristov, E. (2006). Challenges of the accession for the Bulgarian drug agency. Presentation at the '2nd South East Europe Pharmaceutical Symposium', 3 May, Bucharest, Romania.
6. Badescu, R. (2006). New Romanian legislation as part of harmonization process with European legislation. Presentation at the '2nd South East Europe Pharmaceutical Symposium', 3 May, Bucharest, Romania.
7. Kazakov, R. (2006). A flagship reform. Pharmaceutical Marketing Europe Summer, 22-23.
8. Afenliev , V. (2006). EU accession of Bulgaria and Romania: Perspective of the generic medicines industry. Presentation at the '12th EGA Annual Conference', 21-22 September, Budapest, Hungary.
9. Simoens, S. & De Coster, S. (2006). Sustaining Generic Medicines Markets in Europe, Research Centre for Pharmaceutical Care and Pharmaco-economics, Katholieke Universiteit Leuven, pp. 9-13.
10. Kanavos, P. & Gemmill, M. (2005). Pharmaceutical pricing and reimbursement in Europe. Scrip Reports. Strategic Management Report Series, T&F Informa Ltd, London.